Furthermore, when mice carrying established human AML tumors were treated with the anti‐CD47 antibody, there was almost complete elimination of circulating human AML LSC as well as a significant decrease in LSC remaining in the bone marrow. Here, CD47 is linked to acute myeloid leukemia.